Navigation Links
Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial
Date:6/30/2009

als."

The objectives of this multi-center open label dose escalation study are to determine the safety and tolerability of bavituximab in patients with advanced cancer, to characterize the pharmacokinetic profile of bavituximab and to identify dose-limiting toxicities and the maximum tolerated dose and/or maximum effective dose. The trial enrolled patients with breast, colorectal, pancreatic, liver, prostate, and head and neck cancers, as well as melanoma and mesothelioma. With planned enrollment complete, patient dosing and follow-up are continuing.

Bavituximab is a monoclonal antibody with a unique mechanism that enables the body's own immune system to recognize and act on the tumor and its supporting blood vessels, resulting in anti-cancer effects. Bavituximab is currently also being tested in combination with chemotherapy in one Phase II trial in advanced lung cancer and two Phase II trials in advanced breast cancer. All three trials, which have a two-stage design, surpassed the initial efficacy criteria need to expand patient enrollment. Interim results in these trials were very encouraging, with objective tumor response rates that compare favorably to chemotherapy alone. Enrollment is now complete in one of the Phase II breast cancer studies and is continuing in the other two Phase II cancer trials.

About Phosphatidylserine (PS)-Targeting Agents

The rapid and disorganized growth that is the hallmark of cancer results in the exposure of the lipid phosphatidylserine (PS) on the surface of tumor blood vessels. Since these phospholipids are typically not exposed on the surface of normal tissues, they represent a unique target for anti-cancer treatments. Bavituximab is a monoclonal antibody that binds specifically to these phospholipids exposed on the surface of the cells lining tumor blood vessels. Once bound, bavituximab alerts the body's immune system to attack the tumor blood ve
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Positive Results From Peregrine Pharmaceuticals Bavituximab Phase l HCV Trial Presented at AASLD Meeting
2. Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
3. Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials
4. Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals Bavituximab to Cure Lethal Virus Infections
5. Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
6. Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2009
7. Peregrine Pharmaceuticals Bavituximab Achieves Primary Endpoint in First Stage of Phase II Breast Cancer Study
8. Peregrine Pharmaceuticals to Report Third Quarter FY 2009 Financial Results
9. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
10. Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program
11. ASCO Research Foundation Grant Will Support Study of Peregrines Bavituximab in Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... May 20, 2013 The three surgeons ... Medical Group: David A. Abrutyn, M.D., Robert S. Boretz, ... see patients at their current location, 215 Union Avenue, ... has expertise in sports medicine, with emphasis on injuries ... adolescent, and adult patients for a wide range of ...
(Date:5/19/2013)... Boise, Idaho (PRWEB) May 19, 2013 ... restless feet, may be put to an end through ... restless feet may be caused by a number of ... peripheral neuropathy. This is because peripheral neuropathy is characterized ... and these nerves are part of a larger system, ...
(Date:5/19/2013)... May is officially known as Skin Cancer Awareness ... Australia, the country's forerunner in fashionable children’s sun ... to kick off their month long mission to bring ... staggering number of cancer cases diagnosed each year, the ... out what’s causing the epidemic and how to stop ...
(Date:5/19/2013)... , , SATURDAY, May 18 (HealthDay News) -- Vitamin ... overcome the fatigue and decreased muscle strength associated ... research. Extra vitamin D "was associated with ... quality of life and the ability to perform ... research dietitian and doctoral candidate at Trinity College ...
(Date:5/19/2013)... May 19, 2013 According to a May ... many people are self-conscious about the appearance of certain areas ... when diet and exercise fail to tone and tighten these ... to those looking to get the firmest body possible ... effective mini-overview,” says Dr. Simon Ourian, Medical Director of Epione ...
Breaking Medicine News(10 mins):Health News:Summit Medical Group Welcomes the Center for Orthopedic Care 2Health News:Summit Medical Group Welcomes the Center for Orthopedic Care 3Health News:Peripheral Neuropathy Naturally Treatable Through Neuracel's Ultimate Neuropathy Support System 2Health News:Leading Children’s Sun Protection Swimwear Company Platypus Australia use Skin Cancer Awareness Month to Help Educate Parents 2Health News:Leading Children’s Sun Protection Swimwear Company Platypus Australia use Skin Cancer Awareness Month to Help Educate Parents 3Health News:Extra Vitamin D May Ease Crohn's Symptoms, Study Finds 2Health News:Extra Vitamin D May Ease Crohn's Symptoms, Study Finds 3Health News:Body Firming – The Hottest Treatments Available 2
... ... Underwriter Enhances Innovative Solutions for Travelers and Individuals , ... Indianapolis, IN (PRWEB) August 10, ... health insurance, today announced it has signed an agreement with Eldorado Computing, Inc. ...
... ... ... -- Tucson, Arizona is home to a dense Hispanic population. In recognition of September ... the word throughout the local Hispanic community that colorectal pre-screening can save lives., , ...
... cancer can preserve future fertility by keeping at least one ovary ... disease. The study is published in the September 15, 2009 issue ... Society. Most cases of ovarian cancer are diagnosed at later ... ovarian tumors occur in women 40 years of age or younger, ...
... Ultherapy ... more lifted and contoured face? This breakthrough in non-surgical facelift actually delivers all that ... ... of non-surgical facelift. This breakthrough device has the potential to upend the non-surgical facial ...
... ... The 2009 J-1/H-1B Foreign Physician Immigration Conference and Job Fair Series includes ... Baltimore on Oct. 24. The annual series is free and provides ... medical training in the U.S. and residency program directors and coordinators, who ...
... perspective, it may be more efficient to use the drug ... wild-type KRAS gene, according to a study published online August ... . Earlier, patients whose tumors harbored wild-type KRAS were ... cetuximab in a randomized trial by the National Cancer Institute ...
Cached Medicine News:Health News:HCC Medical Insurance Services Selects Eldorado's Innovative Claims & Benefits Platform 2Health News:Hispanics at High Risk for Colorectal Cancer 2Health News:Hispanics at High Risk for Colorectal Cancer 3Health News:Young early stage ovarian cancer patients can preserve fertility 2Health News:The Sloane Clinic pioneers Ultherapy in Singapore 2Health News:The Sloane Clinic pioneers Ultherapy in Singapore 3Health News:14th Annual J-1/H-1B Foreign Physician Immigration Conference and Job Fair Series Kicks-Off in New York City 2Health News:14th Annual J-1/H-1B Foreign Physician Immigration Conference and Job Fair Series Kicks-Off in New York City 3Health News:Cost-effectiveness of cetuximab in metastatic colorectal cancer 2
(Date:5/17/2013)... 17, 2013  Lakeland Industries, Inc. (NASDAQ: ... for industry, healthcare and to first responders on the ... results for the fiscal 2013 fourth quarter and year ... at stock market close and will conduct a conference ... (Logo: http://photos.prnewswire.com/prnh/20120611/NY21959LOGO ) ...
(Date:5/17/2013)... , May 17, 2013  Technology advances have ... internally. Faced with a constantly evolving communication environment, ... tactics for communicating with internal executives. It is ... the strategies, tactics and tools that are part ... a new study, Best Practices, LLC explores the ...
(Date:5/17/2013)... 2013  Sony Biotechnology Inc. ("Sony") today announced the ...  Sony will be exhibiting and taking orders for this ... the San Diego Convention Center ... May 20 - 22.  The SP6800 ... audio-visual technologies into new and novel functionalities for the ...
Breaking Medicine Technology:Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call 2Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2
... Pa., Nov. 17, 2010 Offering another suggestion to ... said today that the commonwealth could save millions of ... Pennsylvania state government spends more than $2 ... million Pennsylvanians, through 17 drug programs overseen by nine ...
... Pa., Nov. 17, 2010 Environmental Tectonics Corporation,s (OTC ... "Company") Sterilization Systems Group announced today that it has ... for three industrial Ethylene Oxide (EtO) Sterilization Systems.   ... to a major multi-national corporation, include material handling systems, ...
Cached Medicine Technology:Auditor General Jack Wagner Says State Could Save Millions by Consolidating Prescription Drug Purchases 2Auditor General Jack Wagner Says State Could Save Millions by Consolidating Prescription Drug Purchases 3Environmental Tectonics Corporation's Sterilization Systems Group Awarded Major Contract 2Environmental Tectonics Corporation's Sterilization Systems Group Awarded Major Contract 3Environmental Tectonics Corporation's Sterilization Systems Group Awarded Major Contract 4
... The DryEase Mini-Gel Drying System is a simple ... evaporation. The kit allows gels to be assembled ... both outer surfaces of the gels are exposed ... is minimized. The proprietary Gel-Dry™ Drying Solution modulates ...
... generations. Most gels can be dried by positioning ... gel dryer, covering them with wet semi-permeable cellophane ... the cellophane flat. Tut's Tombs also produce great ... somewhat larger than the gel to be dried. ...
... Preserve your data for future generations. Most ... the solid backing plate of our gel dryer, ... a frame over them to hold the cellophane ... a frame with an open area somewhat larger ...
Each GelAir™ system drying frame includes two main components, a plastic drying outer frame and a metal square inner frame, as well as 8 clamps per frame. Supplied as a set of two frames....
Medicine Products: